TY -的T1 -广泛的手术后随访的相关性nonsmall细胞肺癌JF -欧洲呼吸杂志》乔和J SP - 1357 LP - 1364欧元——10.1183/09031936.00086712六世- 42 - 5盟戴尔芬Gourcerol AU - Arnaud Scherpereel盟Stephane Debeugny AU - Henri土耳其宫廷盟亚历克西斯b Cortot盟——让-雅克•拉菲特Y1 - 2013/11/01 UR - //www.qdcxjkg.com/content/42/5/1357.abstract N2 -没有国际指导方针,一个适当的和具有成本效益的后续切除nonsmall细胞性肺癌(NSCLC)。我们回顾了非小细胞肺癌患者治疗手术后的结果。每三个月随访包括体格检查及胸部x线摄影,和胸部计算机断层扫描(CT)扫描,支气管镜检查,腹部超声、脑CT扫描和骨扫描每6个月为3年,每年在接下来的2年。预后因素和成本进行分析。中位总生存期的非小细胞肺癌手术后162例患者是38.5个月。复发发生在85年(52.5%),包括41个(48%)病人症状。无病生存之间类似的无症状的复发与患者有症状的患者(11.4和12个月;p = 0.41)。在体检中发现的复发是或47例(55.3%)患者的胸部x线摄影。Curative-intent疗法提供了在18(41%)的44个病人无症状复发和41例症状四条(10%)(p = 0.001)。 Median overall survival from time of recurrence was higher in asymptomatic patients than in symptomatic patients (15.5 versus 7.2 months; p=0.001). The cost per year of life gained was USD32 700 (€22 397). An extensive follow-up, with acceptable cost, may improve the outcome of patients with resected NSCLC through detection of asymptomatic recurrences; however, validation by prospective studies is required. An extensive follow-up, with acceptable cost, may improve the outcome of patients with resected NSCLC http://ow.ly/nUOez ER -